Skip to main content
Premium Trial:

Request an Annual Quote

Brown Leaves Accelrys for SciTegic; NHGRI Disease Chief Nussbaum to Head ASHG; Cellomics Gets a Bigger Board; and others

NEW YORK, Oct. 23-Former Accelrys marketing director Rob Brown has joined the informatics firm SciTegic as Senior Director of Chemoinformatics Marketing, the company said today.

 

Brown will direct the company's Pipeline chemoinformatics applications.

 

At Accelrys, he was also Senior Director of Chemoinformatics Marketing. In addition, he led the company's Combinatorial Chemistry Consortium, an industry-wide tool development collaboration.

 

SciTegic is an informatics software company based in San Diego, Calif.

 


 

Amersham Biosciences subsidiary Imaging Research said on Oct. 22 that it had hired Simon Fogarty as marketing manager.

 

He will direct collaborations and partnerships and build the company's sales and marketing efforts.

 

Fogarty was previously drug discovery product manager at Thermo CRS in Burlington, Canada. There, he was involved in the creation of the company's Dimension4 screening automation platform.

 

Imaging Research is based in St. Catharines, Ontario. It develops software and analytical imaging systems for life sciences research.

 


 

Large Scale Biology Corporation has hired Christine Arakelian as senior director of business development, the company said on October 16.

 

She will work in the company's Germantown, Md. Offices.

 

She was most recently an independent business development consultant, and has practiced as a corporate and licensing attorney in Washington, D.C.

 


 

Cellomics said on Oct. 16 that it had added five new members to its board of directors.

 

The new board directors are Oxford BioScience managing partner Jonathan Fleming, Carl Zeiss board member Norbert Gorney, Vector Fund's Barclay Phillips, Carl Zeiss microimaging division president James Sharp, and Carl Zeiss head of global microscopy Ulrich Simon.

 

The same day, Cellomics said that it had cut 25 percent of its staff and put several major R&D efforts on hold.

 


 

National Human Genome Research Institute genetic disease research chief Robert Nussbaum will take the helm of the American Society of Human Genetics in 2004, NHGRI said on October 15.

 

Nussbaum is currently chief of the Genetic Disease Research Branch and the Inherited Disease Research Branch in NHGRI's intramural research division.

 

ASHG is a professional membership organization for clinicians, academics, genetic counselors and other genetics professionals. It has nearly 8,000 members.

 

Nussbaum will be president of the society and will serve on its board of directors.

 


Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at ///issues/6_21/bioarray_briefs/118570-1.html"

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.